:: NEWS COCKTAIL aka BlahBlahBlog ::
"Everything is being compressed into tiny tablets. You take a little pill of news every day - 23 minutes - and that's supposed to be enough." -Walter Cronkite, RE TV news. The Web has changed that for many, however, and here is an extra dose for your daily news cocktail. This prescription tends to include surveillance and now war-related links, along with the occasional pop culture junk and whatever else seizes my attention as I scan online news sites.:: 11.22.2008 ::
:: Radio Host Has Drug Company Ties ::
New York Times
By GARDINER HARRIS
An influential psychiatrist who was the host of the popular NPR program “The Infinite Mind” earned at least $1.3 million from 2000 to 2007 giving marketing lectures for drugmakers, income not mentioned on the program.
The psychiatrist and radio host, Dr. Frederick K. Goodwin, is the latest in a series of doctors and researchers whose ties to drugmakers have been uncovered by Senator Charles E. Grassley, Republican of Iowa. Dr. Goodwin, a former director of the National Institute of Mental Health, is the first news media figure to be investigated.
Read more here.
A L S O
from BNET
Fred Goodwin Loses NPR Gig Over GlaxoSmithKline Ties
R E L A T E D
Conflicts of Interest May Ensnare Journalists, Too
New York Times
Health reporters may become entangled in the same kinds of ethical conflicts they often expose when accepting industry-sponsored awards and relying on corporate public relations offices, three researchers warn.
Journalism awards consisting of cash prizes and all-expense-paid trips given out by drug companies are among the more “astonishing” financial ties between journalists and drug companies, the authors said. The paper appears in the online edition of the British medical journal BMJ.
Among the prizes cited are the Embrace Award for reporting on urinary incontinence — consisting of trips to Washington, D.C., and Paris — offered by pharmaceutical firms Eli Lilly and Boehringer Ingelheim, as well as another Eli Lilly award for cancer treatment stories that includes a weeklong international trip for two.
The authors also point a finger at journalism training and education programs sponsored by the health care industry and to professorships funded by drug company grants. The writers go on to criticize reporters’ reliance on drug company press officers for referrals to experts or to patients, whose views may have been carefully screened.
Pharmaceutical companies “work really hard to get their message out to the public and physicians through advertisements and continuing medical education and all the other things people hear about, so it makes sense they would go after the media as well,” said Dr. Steven Woloshin, associate professor of medicine at The Dartmouth Institute for Health Policy and Clinical Practice, one of the paper’s authors. “It’s striking that nobody’s been writing about this.”
posted by me
:: 4:11:00 PM [+] ::
...
